Clinical Trial

A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2024 (before its estimated March 26, 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective, interventional, and practical clinical studies
Trial Details
NCT Number NCT06476899
Lead Sponsor Fei Li
Conditions CLL/SLL
Enrollment 60 participants
Start Date 2024-07-24
Primary Completion 2026-03-26 (estimated)
Study Completion 2026-12-26 (estimated)
Updated on ClinicalTrials.gov 2024-06-27